Showing results (501-510 of 652) with videos related to

Sort By:
Pageof 66
The American Journal of Gastroenterology|December 14, 2023
Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance StudyWaqqas Afif, Ramesh P Arasaradnam, Maria T Abreu, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 studySilvio Danese, Jean-Frederic Colombel, Milan Lukas, et al.
Journal of Crohn'S & Colitis|June 22, 2024
Recommendations for Broadening Eligibility Criteria in Inflammatory Bowel Disease Clinical TrialsCorey A Siegel, Victoria Rai, An Outtier, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2022
Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction TreatmentEdward V Loftus, Jean-Frederic Colombel, Ken Takeuchi, et al.
Nature Communications|October 27, 2010
Current drive at plasma densities required for thermonuclear reactorsR Cesario, L Amicucci, A Cardinali, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2025
Upadacitinib Maintenance Therapy in Crohn's Disease: Final Results From the Randomized Phase 3 U-ENDURE StudyRemo Panaccione, Miguel Regueiro, Scott D Lee, et al.
The Lancet. Gastroenterology & Hepatology|January 10, 2025
Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trialBruce E Sands, Remo Panaccione, Geert D'Haens, et al.
The American Journal of Gastroenterology|November 12, 2024
Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's DiseaseDina Kao, Karen Wong, Humberto Jijon, et al.
The New England Journal of Medicine|September 26, 2019
Ustekinumab as Induction and Maintenance Therapy for Ulcerative ColitisBruce E Sands, William J Sandborn, Remo Panaccione, et al.
The American Journal of Gastroenterology|January 8, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical TrialBruce E Sands, David T Rubin, Edward V Loftus, et al.
Pageof 66